INVARIANT LLC for CIGNA CORPORATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to S. 113, the Prescription Pricing for the People Act, and S. 127, the Pharmacy Benefit Manager Transparency Act. Issues related to insulin pricing. Issues related to mental health coverage, workforce, and mental health parity. S. 1001, issues related to the Telehealth Expansion Act. Issues related to the proposed rule on Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations, Mediaid Managed Care Plans, State Medicaid Agencies, Children's Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans on the Federally-facilitated Exchanges, Merit-based Incentive Payment System (MIPS) Eligible Clinicians, and Eligible Hospitals and Critical Access Hospitals in the Medicare Promoting Interoperability Program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN KLEIN | — |
| JOEL SCOTT RICHARD New | Senior Counsel, Rep. Ted Deutch (2017 - 2021); Legislative Assistant/Counsel, Rep. Ted Deutch (2013 - 2017); Legislative Fellow, Rep. Ted Deutch (2012 - 2013) |
| ANNABELL MCWHERTER STOKES | — |
| KATHRYN WISE | — |
Medicare/Medicaid MMM
Issues related to the Improving Seniors' Timely Access to Care Act of 2021. Issues related to Pharmacy Direct and Indirect Remuneration (DIR), including the Contract Year (CY) 2023 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit (Part D) Programs propsed rule. Issues related to the Advanced Notice of Methodological Changes for Calendar Year (CY) 2024 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies; Medicare Program; Contract Year (CY) 2024 Policy and Technical Changes to the Medicare Advantage Progrma, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program; Health Information Technology Standards and Implementation Specifications.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN KLEIN | — |
| ANNABELL MCWHERTER STOKES | — |
| KATHRYN WISE | — |
Defense DEF
Pharmacy issues related to TRICARE and the Fiscal Year 2024 National Defense Authorization Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN KLEIN | — |
| LINDLEY SHERER | — |
| ANNABELL MCWHERTER STOKES | — |
| KATHRYN WISE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.